XSHE
300272
Market cap549mUSD
Oct 09, Last price
6.10CNY
1D
1.33%
1Q
12.34%
Jan 2017
-28.00%
IPO
31.08%
Name
Canature Health Technology Group Co Ltd
Chart & performance
P/E
66.60
P/S
2.03
EPS
0.09
Div yield, %
2.82%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
4.02%
Revenues
1.84b
+9.03%
Net income
56m
-32.98%
CFO
300m
+3.44%
Dividend
Jun 16, 20260.05 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Canature Health Technology Group Co., Ltd. engages in the research, development, manufacture, sale, and service of residential water treatment products. It operates through the following business segments: Water purification and softening equipment, Fireplace and furnace equipment, Maintenance, and Cell storage and other services. Its products include whole house water purifiers, whole house water softeners, commercial purification water dispensers, reverse osmosis membrane water purifiers, multi-control valves, and composite pressure vessels. The company was founded by Jian Guo Qu on February 27, 2001 and is headquartered in Shanghai, China.
Key people
Jian'guo Qu
Chairman of the Board · since 2020
Wenjun Liu
Chief Financial Officer · since 2023
Yanmao Xu
Secretary of the Board · since 2023
Feng Jin
Deputy General Manager, Director · since 2020
Yaming Qu
Vice Chairman of the Board, General Manager · since 2018
Independent Director · since 2023
Independent Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||